Aurora A-IN-10
CAS No. 1158838-45-9
Aurora A-IN-10( TC-S 7010 | TC S 7010 | TCS7010 )
Catalog No. M10550 CAS No. 1158838-45-9
A potent, highly selective Aurora A inhibitor with IC50 of 3.4 nM; displays >1,000-fold selectivity over Aurora B (IC50=3.4 uM) or CDKs.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
2MG | 41 | Get Quote |
|
5MG | 65 | Get Quote |
|
10MG | 114 | Get Quote |
|
25MG | 207 | Get Quote |
|
50MG | 358 | Get Quote |
|
100MG | 533 | Get Quote |
|
500MG | 1152 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAurora A-IN-10
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, highly selective Aurora A inhibitor with IC50 of 3.4 nM; displays >1,000-fold selectivity over Aurora B (IC50=3.4 uM) or CDKs.
-
DescriptionA potent, highly selective Aurora A inhibitor with IC50 of 3.4 nM; displays >1,000-fold selectivity over Aurora B (IC50=3.4 uM) or CDKs; A useful tool compound for investigating the cellular role of Aurora A kinases without the complication of also inhibiting Aurora B.
-
In VitroTCS7010 is exceptionally selective Aurora A inhibitors. TCS7010 is an useful tool compounds for investigating the cellular role of Aurora A kinases without the complication of also inhibiting Aurora B.
-
In Vivo——
-
SynonymsTC-S 7010 | TC S 7010 | TCS7010
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAurora A| Aurora B| Aurora C
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1158838-45-9
-
Formula Weight588.075
-
Molecular FormulaC31H31ClFN7O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=CC=CC=C1Cl)C2=CC=C(NC3=NC(NC4=CC=C(CC(N5CCN(CC)CC5)=O)C=C4)=NC=C3F)C=C2
-
Chemical NameBenzamide, N-(2-chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SP-96
SP-96 is a highly effective and selective inhibitor of Aurora B with an IC50 of 0.316 nM. SP-96 shows selective growth inhibition in NCI60 screening, including MDA-MD-468 (GI50=107 nM). SP-96 can be used in triple negative breast cancer studies.
-
CCT 137690
A potent, orally bioavailable Aurora kinases inhibitor with IC50 of 15/25/19 nM for Aurora A/B/C; displays antiproliferative activity in a range of human tumor cell lines, including SW620 colon carcinoma (GI50=0.30 uM) and A2780 ovarian cancer cell line (GI50=0.14 uM).
-
Raddeanin A
Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.